Opendata, web and dolomites

NiGlucoMon

A Non-Invasive GLUCOse MONitoring device for diabetics based on Stimulated Raman Spectroscopy in a quick, cheap and painless method.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NiGlucoMon project word cloud

Explore the words cloud of the NiGlucoMon project. It provides you a very rough idea of what is the project "NiGlucoMon" about.

complete    molecules    inexpensive    heart    injury    optics    finger    avoidance    transfer    measuring    biggest    blood    manner    plan    spectroscopy    ulcers    day    complications    patent    once    diabetics    obstacles    noise    carry    usable    isolating    dispersing    infection    people    monitor    strips    power    energy    concentration    sight    raman    analyzing    signal    measured    glucose    vessel    readiness    beams    prick    foot    light    interact    normal    formulated    spectrum    promises    chronic    blindness    nerve    serious    today    60    recommended    disliking    proof    painless    risk    kidney    beam    integration    amputations    scattering    price    undergoes    experimental    levels    proportional    overcome    solution    diabetes    implications    times    disease    stimulated    uncontrolled    collecting    transferred    expensive    damage    ratio    technique    invasive    little    diabetic    least    meter    packaging    quick    protocol    pain    leg    fail    created   

Project "NiGlucoMon" data sheet

The following table provides information about the project.

Coordinator
2M ENGINEERING LIMITED 

Organization address
address: SIDNEY STREET 80
city: FOLKSTONE
postcode: CT19 6HQ
website: www.2mel.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.trigonamedical.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2014
 Duration (year-month-day) from 2014-10-01   to  2015-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    2M ENGINEERING LIMITED UK (FOLKSTONE) coordinator 50˙000.00

Map

 Project objective

Today, diabetics must carry out a “finger prick” test as part of their blood glucose level management. It is recommended to do this test at least 4 times a day. Many diabetics fail to do so even once for a number of reasons: pain avoidance, disliking the sight of blood, cost of the test strips, the test protocol and the risk of infection. This failure to manage blood glucose levels has serious long term implications. Heart disease and blood vessel disease are the biggest complications that people with uncontrolled diabetes face. Blood vessel damage or nerve damage also lead to chronic foot and leg ulcers called diabetic foot that can result in amputations. More than 60% of leg and foot amputations not related to an injury are due to diabetes which is also the cause of new blindness and kidney disease. Our solution is a non-invasive glucose monitor that will allow people with diabetes to monitor their blood glucose levels in a quick and painless manner, for a low price. When using normal Raman Spectroscopy very little light undergoes Raman scattering, therefore high integration times are required to achieve a usable signal-to-noise ratio. Expensive optics are necessary for collecting, isolating and dispersing the light. Our technique and system packaging promises to overcome all of these obstacles. We use Stimulated Raman Spectroscopy, created when two light beams interact with each other in the presence of glucose. The energy is transferred from one beam of light to the other, and this transfer is proportional to the number of glucose molecules present. By measuring this energy transfer using a simple and inexpensive power meter, the glucose concentration is measured without the need for dispersing the light and analyzing the Raman Spectrum. A patent has been applied for. We have completed the Technology Readiness Level 2 (technology concept formulated) and plan to complete Technology Readiness Level 3 (Experimental Proof of concept) in this project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIGLUCOMON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIGLUCOMON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More